Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer

[1]  P. Schlag,et al.  Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Joon-Oh Park,et al.  A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer. , 2010, European journal of cancer.

[3]  Hai-rim Shin,et al.  Nationwide cancer incidence in Korea, 2003-2005. , 2009, Cancer research and treatment : official journal of Korean Cancer Association.

[4]  D. Lim,et al.  Phase III trial of adjuvant capecitabine/cisplatin (XP) versus capecitabine/cisplatin/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): Safety analysis. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  I. Choi,et al.  Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer , 2008, Cancer.

[6]  Yasuo Ohashi,et al.  Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. , 2007, The New England journal of medicine.

[7]  J. Ajani,et al.  Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[9]  M. Raderer,et al.  Postoperative chemotherapy for gastric cancer. , 2006, The oncologist.

[10]  Joon-Oh Park,et al.  An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. , 2005, International journal of radiation oncology, biology, physics.

[11]  J. Ajani,et al.  Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Ajani,et al.  Chemoradiation for resectable gastric cancer. , 2003, The Lancet. Oncology.

[13]  Scott A. Hundahl,et al.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2001, The New England journal of medicine.

[14]  D. Gouma,et al.  Extended lymph-node dissection for gastric cancer. , 1999, The New England journal of medicine.

[15]  J. Chmiel,et al.  Cancer of the stomach. A patient care study by the American College of Surgeons. , 1993, Annals of surgery.

[16]  L. Simon,et al.  Cancer of the stomach. , 1951, Connecticut state medical journal.

[17]  M. Brennan,et al.  Selection of patients with gastric adenocarcinoma for laparoscopic staging. , 2006, American journal of surgery.

[18]  M. Huguier,et al.  [Extended lymph-node dissection for gastric cancer]. , 1999, Chirurgie; memoires de l'Academie de chirurgie.

[19]  J. Sanger,et al.  Review of Consecutive Ten Year Intervals , 1979 .

[20]  C. McConkey,et al.  Cancer of the stomach. , 1989 .